2.
Masaoka分期为晚期时两组患者的相关资料
The specific analysis of late Masaoka stage patients between two groups
| MG (n=142) | non-MG (n=605) | P | |
| 注:本表得到版权所有者©2011-2016 Journal of Thoracic Disease复制许可。 | |||
| Masaoka stage | 0.128 | ||
| Ⅲ | 116 (81.7%) | 458 (75.7%) | |
| Ⅳ | 26(18.3%) | 147 (24.3%) | |
| WHO classification | < 0.001 | ||
| A | 2 (1.4%) | 14 (2.3%) | |
| AB | 15 (10.6%) | 38 (6.3%) | |
| B1 | 19 (13.4%) | 29 (4.8%) | |
| B2 | 39 (27.5%) | 71 (11.7%) | |
| B3 | 54 (38.0%) | 154(25.5%) | |
| C | 13 (9.2%) | 273 (45.1%) | |
| Carcinoid | 0 (0.0%) | 26 (4.3%) | |
| Complete thymectomy | 122 (86.5%) | 434 (72.7%) | 0.001 |
| Tumor size | 6.4 | 7.9 | < 0.001 |
| Resectability | 104(73.2%) | 400 (66.4%) | 0.119 |
| Recurrence | 16(15.7%) | 137 (31.7%) | 0.001 |